BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:06 PM
 | 
Feb 24, 2009
 |  BC Extra  |  Clinical News

Aveo reports RCC data

Aveo (Cambridge, Mass.) said interim data from a Phase II trial to treat metastatic renal cell carcinoma (RCC) showed that oral, once-daily AV-951 resulted...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >